デフォルト表紙
市場調査レポート
商品コード
1439193

グルコースモニタリングシステムの世界市場の評価:タイプ別、コンポーネント別、製品別、患者ケア環境別、用途別、モダリティ別、侵襲性別、流通チャネル別、地域別、機会、予測(2017年~2031年)

Glucose Monitoring System Market Assessment, By Type, By Component, By Product, By Patient Care Setting, By Application, By Modality, By Invasiveness, By Distribution Channel, By Region, By Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 226 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
グルコースモニタリングシステムの世界市場の評価:タイプ別、コンポーネント別、製品別、患者ケア環境別、用途別、モダリティ別、侵襲性別、流通チャネル別、地域別、機会、予測(2017年~2031年)
出版日: 2024年02月28日
発行: Market Xcel - Markets and Data
ページ情報: 英文 226 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のグルコースモニタリングシステムの市場規模は、2023年の252億1,000万米ドルから2031年に554億3,000万米ドルに達し、予測期間の2024年~2031年にCAGRで10.35%の成長が見込まれています。市場の主な促進要因は、世界の糖尿病患者の増加、技術の継続的な進歩、非侵襲性のモニタリングに対する患者の選好、糖尿病管理における定期的な血糖モニタリングの重要性に対する意識の高まり、政府の取り組みや医療改革の増加、医療費の増加、老年人口の増加、遠隔医療やデジタルヘルスプラットフォームとグルコースモニタリングの統合などです。

世界のグルコースモニタリング市場を推進する主なカタリストは、糖尿病、特に不健康な食習慣や座りがちなライフスタイルなどのライフスタイル要因と密接に関連する2型糖尿病の罹患率の上昇です。世界の糖尿病人口が予測可能な将来に大幅な増加を示すと予測されているため、信頼性が高く効率的な血糖モニタリングソリューションに対する需要が急増しています。さらに、血糖モニタリングは技術の進歩によって革新され、持続グルコースモニタリング(CGM)システム、インテリジェントグルコースメーター、モバイルヘルスアプリケーションなどの革新的なデバイスを生み出しています。これらのブレイクスルーは、リアルタイムのデータを提供し、利便性と使いやすさを高め、患者アドヒアランスの強化と医療転帰の全体的な向上に寄与しています。

さらに、計画的な同盟、統合、企業買収が競合環境を再構築しています。これらの協業は、製品の範囲を広げ、世界市場への浸透を強化し、研究開発活動を促進することを目的としています。最終的には、糖尿病患者が利用できるモニタリングと管理の選択肢を増やし、改良型のソリューションを提供し、それによって世界のグルコースモニタリング市場を牽引します。

糖尿病患者の世界的な増加

糖尿病患者の世界的な増加が、世界のグルコースモニタリングシステム市場の成長につながっています。現在、全世界で5億人以上の人々が糖尿病を患っており、この疾患はあらゆる国の性別や年齢層にまたがっています。この数は今後30年以内に13億人を突破すると予測されており、どの国でも増加傾向が見られます。現在、世界の糖尿病の有病率は6.1%で、世界の死因、障害原因の上位10件に入っています。各地域に注目すると、北アフリカと中東の有病率が9.3%ともっとも高く、2050年までに16.8%に急増すると予測されています。同様に、ラテンアメリカとカリブ海諸国では11.3%に上昇すると予測されています。糖尿病は、どの国でも65歳以上の高齢者に顕著であり、この層の有病率は世界規模で20%を超えています。もっとも有病率が高かったのは75歳~79歳の層で、24.4%に達しました。各地域のデータを分析すると、北アフリカと中東がもっとも高く、39.4%でした。一方、中欧、東欧、中央アジアは19.8%ともっとも低くなっています。

技術の進歩が市場を牽引

技術の進歩が世界のグルコースモニタリングシステム市場を強化しています。その結果、血糖モニタリングデバイスの採用が増加しており、糖尿病管理の強化につながっています。複数のウェアラブルグルコースモニタリングデバイスが開発中であり、糖尿病患者に指を刺す必要なく血糖値をモニタリングする能力を提供しています。プロセスを合理化し、医療従事者に価値ある臨床的知見を提供し、最終的に優れた患者ケアを提供する能力を高めるために、新たなソリューションが導入されています。例えば、2024年2月6日、糖尿病患者向け持続グルコースモニタリング(CGM)の世界的リーダーであるDexComは、同社の最新CGMデバイスであるDexcom ONE+の発売を発表しました。このシステムはまもなくオランダで導入され、現在スペイン、ベルギー、ポーランドで利用可能です。Dexcom ONE+には、Dexcomのもっとも正確なクラス最高のセンサー設計が採用されています。

当レポートでは、世界のグルコースモニタリングシステム市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 COVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のグルコースモニタリングシステム市場の見通し(2017年~2031年)

  • 市場規模と予測
    • 金額
    • 数量
  • タイプ別
    • 自己モニタリング血糖(SMBG)システム
    • 持続グルコースモニタリング(CGM)システム
  • コンポーネント別
    • 血糖計デバイス
    • テストストリップ
    • ランセット
    • センサー
    • 耐久消費財
  • 製品別
    • デバイス
    • サービス
  • 患者ケア環境別
    • 病院
    • 在宅ケア
  • 用途別
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病
  • モダリティ別
    • ウェアラブル
    • 非ウェアラブル
  • 侵襲性別
    • 侵襲的手法
    • 低侵襲手法
    • 非侵襲的手法
  • 流通チャネル別
    • 小売店
    • eコマース
    • 薬局
  • 地域別
    • 北米
    • 欧州
    • 南米
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア:企業別(2023年)

第6章 世界のグルコースモニタリングシステム市場の見通し:地域別(2017年~2031年)

  • 北米
    • 市場規模と予測
    • タイプ別
    • コンポーネント別
    • 製品別
    • 患者ケア環境別
    • 用途別
    • モダリティ別
    • 侵襲性別
    • 流通チャネル別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第7章 市場マッピング(2023年)

  • タイプ別
  • コンポーネント別
  • 製品別
  • 患者ケア環境別
  • 用途別
  • モダリティ別
  • 侵襲性別
  • 流通チャネル別
  • 地域別

第8章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第9章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第10章 規制枠組みとイノベーション

  • 臨床試験
  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第11章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2023年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場参入企業5社)
  • 特許分析(該当する場合)

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • LifeScan IP Holdings
  • Ascensia Diabetes Care Holdings AG.
  • Medtronic Plc.
  • Dexcom, Inc.
  • Ypsomed AG
  • B. Braun Medical Ltd.
  • Nipro Corporation
  • Sanofi S.A.

第15章 戦略的推奨事項

第16章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 4. Global Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 5. Global Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 6. Global Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 7. Global Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 8. Global Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 9. Global Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 10. Global Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 11. Global Glucose Monitoring Market Share (%), By Region, 2017-2031F
  • Figure 12. North America Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 13. North America Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 14. North America Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 15. North America Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 16. North America Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 17. North America Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 18. North America Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 19. North America Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 20. North America Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 21. North America Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 22. North America Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 23. United States Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. United States Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 25. United States Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 26. United States Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 27. United States Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 28. United States Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 29. United States Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 30. United States Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 31. United States Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 32. United States Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 33. Canada Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Canada Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Canada Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 36. Canada Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 37. Canada Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 38. Canada Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 39. Canada Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 40. Canada Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 41. Canada Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 42. Canada Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 43. Mexico Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 44. Mexico Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 45. Mexico Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 46. Mexico Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 47. Mexico Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 48. Mexico Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 49. Mexico Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 50. Mexico Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 51. Mexico Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 52. Mexico Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 53. Europe Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. Europe Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 55. Europe Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 56. Europe Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 57. Europe Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 58. Europe Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 59. Europe Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 60. Europe Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 61. Europe Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 62. Europe Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 63. Europe Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 64. Germany Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Germany Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Germany Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 67. Germany Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 68. Germany Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 69. Germany Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 70. Germany Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 71. Germany Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 72. Germany Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 73. Germany Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 74. France Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. France Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 76. France Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 77. France Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 78. France Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 79. France Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 80. France Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 81. France Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 82. France Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 83. France Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 84. Italy Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 85. Italy Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 86. Italy Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 87. Italy Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 88. Italy Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 89. Italy Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 90. Italy Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 91. Italy Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 92. Italy Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 93. Italy Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. United Kingdom Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. United Kingdom Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. United Kingdom Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 97. United Kingdom Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 98. United Kingdom Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 99. United Kingdom Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 100. United Kingdom Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 101. United Kingdom Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 102. United Kingdom Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 103. United Kingdom Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 104. Russia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 105. Russia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 106. Russia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 107. Russia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 108. Russia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 109. Russia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 110. Russia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 111. Russia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 112. Russia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 113. Russia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 114. Netherlands Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 115. Netherlands Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 116. Netherlands Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 117. Netherlands Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 118. Netherlands Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 119. Netherlands Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 120. Netherlands Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 121. Netherlands Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 122. Netherlands Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 123. Netherlands Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 124. Spain Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Spain Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 126. Spain Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 127. Spain Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 128. Spain Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 129. Spain Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 130. Spain Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 131. Spain Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 132. Spain Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 133. Spain Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 134. Turkey Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 135. Turkey Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 136. Turkey Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 137. Turkey Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 138. Turkey Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 139. Turkey Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 140. Turkey Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 141. Turkey Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 142. Turkey Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 143. Turkey Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 144. Poland Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Poland Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Poland Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 147. Poland Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 148. Poland Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 149. Poland Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 150. Poland Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 151. Poland Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 152. Poland Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 153. Poland Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 154. South America Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 155. South America Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 156. South America Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 157. South America Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 158. South America Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 159. South America Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 160. South America Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 161. South America Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 162. South America Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 163. South America Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 164. South America Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 165. Brazil Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 166. Brazil Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 167. Brazil Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 168. Brazil Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 169. Brazil Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 170. Brazil Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 171. Brazil Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 172. Brazil Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 173. Brazil Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 174. Brazil Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 175. Argentina Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Argentina Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Argentina Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 178. Argentina Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 179. Argentina Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 180. Argentina Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 181. Argentina Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 182. Argentina Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 183. Argentina Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 184. Argentina Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 185. Asia-Pacific Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 186. Asia-Pacific Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 187. Asia-Pacific Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 188. Asia-Pacific Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 189. Asia-Pacific Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 190. Asia-Pacific Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 191. Asia-Pacific Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 192. Asia-Pacific Glucose Monitoring Market Share (%), By Modality, 2016-2030
  • Figure 193. Asia-Pacific Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 194. Asia-Pacific Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195. Asia-Pacific Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 196. India Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 197. India Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 198. India Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 199. India Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 200. India Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 201. India Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 202. India Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 203. India Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 204. India Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 205. India Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 206. China Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 207. China Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 208. China Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 209. China Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 210. China Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 211. China Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 212. China Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 213. China Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 214. China Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 215. China Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 216. Japan Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 217. Japan Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 218. Japan Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 219. Japan Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 220. Japan Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 221. Japan Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 222. Japan Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 223. Japan Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 224. Japan Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 225. Japan Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 226. Australia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 227. Australia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 228. Australia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 229. Australia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 230. Australia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 231. Australia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 232. Australia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 233. Australia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 234. Australia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 235. Australia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 236. Vietnam Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 237. Vietnam Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 238. Vietnam Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 239. Vietnam Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 240. Vietnam Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 241. Vietnam Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 242. Vietnam Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 243. Vietnam Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 244. Vietnam Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 245. Vietnam Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 246. South Korea Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 247. South Korea Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 248. South Korea Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 249. South Korea Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 250. South Korea Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 251. South Korea Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 252. South Korea Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 253. South Korea Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 254. South Korea Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 255. South Korea Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 256. Indonesia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 257. Indonesia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 258. Indonesia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 259. Indonesia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 260. Indonesia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 261. Indonesia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 262. Indonesia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 263. Indonesia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 264. Indonesia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 265. Indonesia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 266. Philippines Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 267. Philippines Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 268. Philippines Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 269. Philippines Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 270. Philippines Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 271. Philippines Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 272. Philippines Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 273. Philippines Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 274. Philippines Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 275. Philippines Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 276. Middle East & Africa Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 277. Middle East & Africa Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 278. Middle East & Africa Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 279. Middle East & Africa Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 280. Middle East & Africa Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 281. Middle East & Africa Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 282. Middle East & Africa Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 283. Middle East & Africa Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 284. Middle East & Africa Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 285. Middle East & Africa Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 286. Middle East & Africa Glucose Monitoring Market Share (%), By Country, 2017-2031F
  • Figure 287. Saudi Arabia Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 288. Saudi Arabia Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 289. Saudi Arabia Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 290. Saudi Arabia Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 291. Saudi Arabia Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 292. Saudi Arabia Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 293. Saudi Arabia Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 294. Saudi Arabia Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 295. Saudi Arabia Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 296. Saudi Arabia Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 297. UAE Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 298. UAE Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 299. UAE Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 300. UAE Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 301. UAE Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 302. UAE Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 303. UAE Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 304. UAE Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 305. UAE Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 306. UAE Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 307. South Africa Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
  • Figure 308. South Africa Glucose Monitoring Market, By Volume, In Million Units, 2017-2031F
  • Figure 309. South Africa Glucose Monitoring Market Share (%), By Types, 2017-2031F
  • Figure 310. South Africa Glucose Monitoring Market Share (%), By Component, 2017-2031F
  • Figure 311. South Africa Glucose Monitoring Market Share (%), By Product, 2017-2031F
  • Figure 312. South Africa Glucose Monitoring Market Share (%), By Patient Care Setting, 2017-2031F
  • Figure 313. South Africa Glucose Monitoring Market Share (%), By Application, 2017-2031F
  • Figure 314. South Africa Glucose Monitoring Market Share (%), By Modality, 2017-2031F
  • Figure 315. South Africa Glucose Monitoring Market Share (%), By Invasiveness, 2017-2031F
  • Figure 316. South Africa Glucose Monitoring Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 317. By Types Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 318. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 319. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 320. By Patient Care Setting Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 321. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 322. By Modality Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 323. By Invasiveness Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 324. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 325. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11029

Global glucose monitoring system market is projected to witness a CAGR of 10.35% during the forecast period 2024-2031, growing from USD 25.21 billion in 2023 to USD 55.43 billion in 2031. Several key factors that are driving the global glucose monitoring market include a global increase in diabetes cases, ongoing advancements in technology, patient preference for non-invasive monitoring, growing awareness about the importance of regular blood glucose monitoring in diabetes management, increased government initiatives and healthcare reforms, rising healthcare expenditure, growing aging population, and the integration of glucose monitoring with telemedicine and digital health platforms.

A primary catalyst propelling the global glucose monitoring market is the escalating incidence of diabetes, especially type 2 diabetes, closely associated with lifestyle factors such as unhealthy dietary habits and sedentary lifestyles. As the global diabetic population is projected to experience substantial growth in the foreseeable future, there is a burgeoning demand for dependable and efficient blood glucose monitoring solutions. Additionally, blood glucose monitoring has been revolutionized by technological advancements, giving rise to innovative devices such as continuous glucose monitoring (CGM) systems, intelligent glucose meters, and mobile health applications. These breakthroughs deliver real-time data and provide heightened convenience and user-friendliness, contributing to enhanced patient adherence and overall improvements in healthcare outcomes.

Moreover, deliberate alliances, consolidations, and corporate takeovers are reconfiguring the competitive environment. These cooperative ventures aim to broaden product ranges, augmenting worldwide market penetration and expediting research and development initiatives. In the end, they serve to advance the monitoring and management options available to individuals with diabetes, offering them improved solutions, hence driving the global glucose monitoring market.

Global Increase in Diabetes Cases

The global increase in the number of diabetes cases has led to the growth of the global glucose monitoring system market. Over 500 million individuals across the globe are currently grappling with diabetes, a condition that spans across gender and age groups in all nations. This number is expected to surpass 1.3 billion within the next three decades, with an upward trend witnessed in every country. Currently, diabetes boasts a global prevalence rate of 6.1%, firmly placing it among the top 10 leading causes of death and disability worldwide. Zooming in on super-regions, North Africa and the Middle East exhibit the highest rate at 9.3%, which is anticipated to surge to 16.8% by 2050. Similarly, the projected rate is set to rise to 11.3% in Latin America and the Caribbean. Diabetes was notably prominent among individuals aged 65 and above across all countries, registering a prevalence rate of over 20% for this demographic on a global scale. The highest rate was observed in the age bracket of 75 to 79, reaching 24.4%. Analyzing the data by super-regions, North Africa and the Middle Eas t had the highest rate within this age group, 39.4%. At the same time, Central Europe, Eastern Europe, and Central Asia displayed the lowest rate at 19.8%.

Technological Advancements are Driving the Market

Advancements in technology are enhancing the global glucose monitoring system market. Consequently, there is a growing adoption of blood glucose monitoring devices, resulting in enhanced diabetes management. Multiple wearable glucose monitoring devices are in the works, offering people with diabetes the ability to monitor their blood sugar levels without the need for finger pricking. Emerging solutions are being introduced to streamline processes and provide healthcare professionals with valuable clinical insights, ultimately enhancing their ability to deliver superior patient care. For example, on February 6, 2024, DexCom, Inc., a world leader in continuous glucose monitoring (CGM) for those with diabetes, announced the release of Dexcom ONE+, their newe st CGM device. The system will soon be introduced in the Netherlands and is currently accessible in Spain, Belgium, and Poland. The most accurate and best-in-class sensor design from Dexcom is used in Dexcom ONE+.

Government Initiatives

Notable rise in government initiatives focused on glucose monitoring devices has led to increased growth of global glucose monitoring system market. These initiatives reflect a coordinated endeavor by governments to confront the complexities associated with diabetes and improve the well-being of those affected by the condition. These efforts encompass a spectrum of policies, regulations, and programs aimed at advancing the accessibility, affordability, and efficacy of glucose monitoring devices, to improve diabetes management and healthcare results. For instance, in March 2022, the government of England unveiled a significant initiative where life-altering flash glucose monitors were provided to all individuals with type 1 diabe tes. These compact wearable devices, approximately the size of a £2 coin, feature a sensor conveniently placed on the arm, enabling patients to swiftly assess their glucose levels with a mere one-second scan. These monitors seamlessly connect to a user-friendly smartphone app, granting individuals access to the data collected by the device.

Growing Popularity of Continuous Glucose Monitoring (CGM) Systems

The worldwide incidence of diabetes is on the rise, resulting in a heightened growth in the global glucose monitoring market. Individuals with diabetes are becoming increasingly conscious of the significance of regular blood glucose level monitoring to prevent conditions like hypoglycemia and hyperglycemia, prompting an increased adoption of continuous glucose monitoring (CGM) systems. CGM systems offer greater convenience compared to traditional fingerstick blood glucose monitoring methods. Moreover, CGM systems provide greater precision and dependability, offering individuals a precise depiction of their blood glucose levels. For example, in April 2023, Abbott Laborator ies, American multinational medical devices, and health care company, revealed that the U.S. Food and Drug Administration (FDA) had approved a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system. This system incorporates the world's most compact, slim, and inconspicuous glucose sensor. CGM systems have a higher stake in the growth of the global glucose monitoring system market.

Increasing Demand for Sensor-based Glucose Monitoring System

Sensor technology has seen remarkable progress in recent years, resulting in the scaling of the global glucose monitoring system market. The sensors within glucose monitoring systems offer improved accuracy and reliability, while also providing increased user convenience. A minute sensor can be inserted beneath the skin, commonly in the abdominal or arm area, and secured with an adhesive patch. These sensors are referred to as disposable sensors. Alternatively, another kind of CGM sensor, an implantable sensor, can be positioned inside your body. In April 2023, Medtronic, a renowned global leader in medical technology, disclosed that the U.S. Food and Drug Administration (FDA) had approved its MiniMed 780G system, featuring the Guardia 4 sensor, eliminating the need for fingersticks when utilizing SmartGua rd technology. The sensor is designed for one-time use and necessitates a prescription. The Guardian 4 sensor is approved for continuous use for seven days.

Impact of COVID-19

The global glucose monitoring system market experienced a notable surge during the COVID-19 pandemic and is poised for robust growth, remaining resilient in the face of significant disruptions caused by the pandemic. One technology that has proven invaluable during the pandemic is real-time continuous glucose monitoring (rtCGM). RtCGM aids individuals with diabetes in enhancing and controlling their glycemic levels, effectively reducing both hyperglycemia and hypoglycemia. In three areas rtCGM emerged as a potent tool for diabetes management during the COVID-19 pandemic. Firstly, rtCGM assisted individuals within the community in managing their diabete s while under lockdown. Secondly, rtCGM was used in telehealth to enable clinics to monitor their patients remotely. Lastly, rtCGM was employed within hospitals to track patient glucose levels and minimize healthcare provider exposure to COVID-19. Therefore, the pandemic positively impacted the global glucose monitoring system market.

Key Players Landscape and Outlook

Within the dynamic of global glucose monitoring system market, mergers and collaborations play a crucial role. Corporations are actively establishing alliances to boost their product portfolios, extend their market presence, and drive innovation. This collective effort is directed toward delivering advanced solutions for diabetes management in the continuously evolving healthcare environment. In February 2023, Ascensia Diabetes Care, a leading worldwide company in diabetes care known for producing the CONTOUR Blood Glucose Monitoring (BGM) system portfolio and serving as the exclusive distributor of Eversense Continuous Glucose Monitoring (CGM) Systems, unve iled a significant international partnership with SNAQ, a highly acclaimed app-based solution that provides essential information on food and nutrition tailored for individuals with diabetes. Through their collaborative efforts to merge their technologies, Ascensia and SNAQ aim to empower a larger number of people with diabetes (PWDs) to make informed decisions about their meals, ultimately striving to enhance diabetes management.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19

4. Executive Summary

5. Global Glucose Monitoring System Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. Self-Monitoring Blood Glucose (SMBG) Systems
    • 5.2.2. Continuous Glucose Monitoring (CGM) Systems
      • 5.2.1.1. Real-time CGM
      • 5.2.1.2. Intermittently Scanned CGM
  • 5.3. By Component
    • 5.3.1. Glucometer devices
    • 5.3.2. Test Strips
    • 5.3.3. Lancets
    • 5.3.4. Sensors
    • 5.3.5. Durables
  • 5.4. By Product
    • 5.4.1. Devices
    • 5.4.2. Services
  • 5.5. By Patient Care Setting
    • 5.5.1. Hospital
    • 5.5.2. Homecare
  • 5.6. By Application
    • 5.6.1. Type 1 Diabetes
    • 5.6.2. Type 2 Diabetes
    • 5.6.3. Gestational Diabetes
  • 5.7. By Modality
    • 5.7.1. Wearable
    • 5.7.2. Non-wearable
  • 5.8. By Invasiveness
    • 5.8.1. Invasive methods
    • 5.8.2. Minimally Invasive methods
    • 5.8.3. Non-invasive methods
  • 5.9. By Distribution Channel
    • 5.9.1. Retail Stores
    • 5.9.2. E-commerce
    • 5.9.3. Pharmacy
  • 5.10. By Region
    • 5.10.1. North America
    • 5.10.2. Europe
    • 5.10.3. South America
    • 5.10.4. Asia-Pacific
    • 5.10.5. Middle East and Africa
  • 5.11. By Company Market Share (%), 2023

6. Global Glucose Monitoring System Market Outlook, By Region, 2017-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Type
      • 6.1.2.1. Self-Monitoring Blood Glucose (SMBG) Systems
      • 6.1.2.2. Continuous Glucose Monitoring (CGM) Systems
      • 6.1.2.2.1. Real-time CGM
      • 6.1.2.2.2. Intermittently Scanned CGM
    • 6.1.3. By Component
      • 6.1.3.1. Glucometer devices
      • 6.1.3.2. Test Strips
      • 6.1.3.3. Lancets
      • 6.1.3.4. Sensors
      • 6.1.3.5. Durables
    • 6.1.4. By Product
      • 6.1.4.1. Devices
      • 6.1.4.2. Services
    • 6.1.5. By Patient Care Setting
      • 6.1.5.1. Hospital
      • 6.1.5.2. Homecare
    • 6.1.6. By Application
      • 6.1.6.1. Type 1 Diabetes
      • 6.1.6.2. Type 2 Diabetes
      • 6.1.6.3. Gestational Diabetes
    • 6.1.7. By Modality
      • 6.1.7.1. Wearable
      • 6.1.7.2. Non-wearable
    • 6.1.8. By Invasiveness
      • 6.1.8.1. Invasive methods
      • 6.1.8.2. Minimally Invasive methods
      • 6.1.8.3. Non-invasive methods
    • 6.1.9. By Distribution Channel
      • 6.1.9.1. Retail stores
      • 6.1.9.2. E-commerce
      • 6.1.9.3. Pharmacy
    • 6.1.10. United States*
      • 6.1.10.1. Market Size & Forecast
      • 6.1.10.1.1. Value
      • 6.1.10.1.2. Volume
      • 6.1.10.2. By Type
      • 6.1.10.2.1. Self-Monitoring Blood Glucose (SMBG) Systems
      • 6.1.10.2.2. Continuous Glucose Monitoring (CGM) Systems
      • 6.1.10.2.2.1. Real-time CGM
      • 6.1.10.2.2.2. Intermittently Scanned CGM
      • 6.1.10.3. By Component
      • 6.1.10.3.1. Glucometer devices
      • 6.1.10.3.2. Test Strips
      • 6.1.10.3.3. Lancets
      • 6.1.10.3.4. Sensors
      • 6.1.10.3.5. Durables
      • 6.1.10.4. By Product
      • 6.1.10.4.1. Devices
      • 6.1.10.4.2. Services
      • 6.1.10.5. By Patient Care Setting
      • 6.1.10.5.1. Hospital
      • 6.1.10.5.2. Homecare
      • 6.1.10.6. By Application
      • 6.1.10.6.1. Type 1 Diabetes
      • 6.1.10.6.2. Type 2 Diabetes
      • 6.1.10.6.3. Gestational Diabetes
      • 6.1.10.7. By Modality
      • 6.1.10.7.1. Wearable
      • 6.1.10.7.2. Non-wearable
      • 6.1.10.8. By Invasiveness
      • 6.1.10.8.1. Invasive methods
      • 6.1.10.8.2. Minimally invasive methods
      • 6.1.10.8.3. Non-invasive methods
      • 6.1.10.9. By Distribution Channel
      • 6.1.10.9.1. Retail Stores
      • 6.1.10.9.2. E-commerce
      • 6.1.10.9.3. Pharmacy
    • 6.1.11. Canada
    • 6.1.12. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Component
  • 7.3. By Product
  • 7.4. By Patient Care Setting
  • 7.5. By Application
  • 7.6. By Modality
  • 7.7. By Invasiveness
  • 7.8. By Distribution Channel
  • 7.9. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Hoffmann-La Roche Ltd.
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Abbott Laboratories
  • 14.3. LifeScan IP Holdings
  • 14.4. Ascensia Diabetes Care Holdings AG.
  • 14.5. Medtronic Plc.
  • 14.6. Dexcom, Inc.
  • 14.7. Ypsomed AG
  • 14.8. B. Braun Medical Ltd.
  • 14.9. Nipro Corporation
  • 14.10. Sanofi S.A.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer